Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Boai NKY Medical Holdings Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 4/6
Boai NKY Medical Holdings has been growing earnings at an average annual rate of 39.2%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 14.3% per year. Boai NKY Medical Holdings's return on equity is 12.8%, and it has net margins of 28.8%.
Anahtar bilgiler
39.2%
Kazanç büyüme oranı
36.6%
EPS büyüme oranı
Chemicals Sektör Büyümesi | 12.1% |
Gelir büyüme oranı | 14.3% |
Özkaynak getirisi | 12.8% |
Net Marj | 28.8% |
Sonraki Kazanç Güncellemesi | 23 Oct 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Boai NKY Medical Holdings Ltd. (SZSE:300109) Doing What It Can To Lift Shares
Aug 23Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?
Jul 25Boai NKY Medical Holdings (SZSE:300109) Is Paying Out A Larger Dividend Than Last Year
Jun 04We Like These Underlying Return On Capital Trends At Boai NKY Medical Holdings (SZSE:300109)
May 27Should You Be Adding Boai NKY Medical Holdings (SZSE:300109) To Your Watchlist Today?
Apr 03Boai NKY Medical Holdings Ltd. (SZSE:300109) Stock Rockets 39% But Many Are Still Ignoring The Company
Mar 04Gelir ve Gider Dağılımı
Boai NKY Medical Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 1,539 | 444 | 235 | 76 |
31 Mar 24 | 1,615 | 494 | 247 | 66 |
31 Dec 23 | 1,583 | 493 | 245 | 64 |
30 Sep 23 | 1,566 | 419 | 242 | 61 |
30 Jun 23 | 1,586 | 408 | 248 | 66 |
31 Mar 23 | 1,538 | 379 | 230 | 66 |
01 Jan 23 | 1,486 | 291 | 234 | 66 |
30 Sep 22 | 1,481 | 385 | 239 | 62 |
30 Jun 22 | 1,362 | 270 | 257 | 60 |
31 Mar 22 | 1,246 | 177 | 270 | 65 |
01 Jan 22 | 1,220 | 207 | 265 | 76 |
30 Sep 21 | 1,158 | 68 | 280 | 72 |
30 Jun 21 | 1,070 | 77 | 249 | 71 |
31 Mar 21 | 1,043 | 95 | 216 | 75 |
31 Dec 20 | 979 | 45 | 220 | 70 |
30 Sep 20 | 950 | 96 | 204 | 75 |
30 Jun 20 | 973 | 113 | 187 | 70 |
31 Mar 20 | 987 | 106 | 198 | 58 |
31 Dec 19 | 924 | 123 | 175 | 49 |
30 Sep 19 | 879 | 113 | 159 | 49 |
30 Jun 19 | 785 | 96 | 143 | 48 |
31 Mar 19 | 716 | 94 | 137 | 51 |
31 Dec 18 | 698 | 90 | 125 | 51 |
30 Sep 18 | 621 | 98 | 104 | 45 |
30 Jun 18 | 567 | 95 | 83 | 53 |
31 Mar 18 | 522 | 93 | 77 | 41 |
31 Dec 17 | 489 | 93 | 83 | 33 |
30 Sep 17 | 455 | 91 | 79 | 19 |
30 Jun 17 | 429 | 89 | 94 | 0 |
31 Mar 17 | 414 | 84 | 85 | 0 |
31 Dec 16 | 401 | 80 | 78 | 0 |
30 Sep 16 | 381 | 82 | 68 | 0 |
30 Jun 16 | 366 | 74 | 68 | 0 |
31 Mar 16 | 320 | 64 | 57 | 0 |
31 Dec 15 | 291 | 57 | 53 | 0 |
30 Sep 15 | 263 | 46 | 46 | 0 |
30 Jun 15 | 255 | 42 | 40 | 0 |
31 Mar 15 | 256 | 38 | 40 | 0 |
31 Dec 14 | 253 | 30 | 38 | 0 |
30 Sep 14 | 243 | 27 | 35 | 0 |
30 Jun 14 | 223 | 23 | 34 | 0 |
31 Mar 14 | 217 | 21 | 33 | 0 |
31 Dec 13 | 209 | 20 | 32 | 0 |
Kaliteli Kazançlar: 300109 has high quality earnings.
Büyüyen Kar Marjı: 300109's current net profit margins (28.8%) are higher than last year (25.7%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 300109's earnings have grown significantly by 39.2% per year over the past 5 years.
Büyüme Hızlandırma: 300109's earnings growth over the past year (8.9%) is below its 5-year average (39.2% per year).
Kazançlar vs. Sektör: 300109 earnings growth over the past year (8.9%) exceeded the Chemicals industry -4.7%.
Özkaynak Getirisi
Yüksek ROE: 300109's Return on Equity (12.8%) is considered low.